NCT04383600 is a NA clinical trial of Micro-osteoperforation in Dental Malocclusions, sponsored by Ahmed Akram Elawady.

Who is sponsoring NCT04383600?

NCT04383600 is sponsored by Ahmed Akram Elawady.

What drugs are being tested in NCT04383600?

Interventions in NCT04383600: Micro-osteoperforation.

What condition does NCT04383600 study?

NCT04383600 studies Dental Malocclusions, Angle Class II, Division 1, Bimaxillary Protrusion.

Is NCT04383600 still recruiting?

NCT04383600 is currently completed. Last updated 12 May 2020.

Last reviewed 2020-05-12 · How we verify

NCT04383600

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Flapless Mops for Acceleration of Canine Retraction

Completed NA Last updated 12 May 2020

What this trial tests

NA trial testing Micro-osteoperforation in Dental Malocclusions in 12 participants. Completed in 5 June 2019.

Timeline

1 September 2017

Primary endpoint
15 May 2019

5 June 2019

Quick facts

Lead sponsor	Ahmed Akram Elawady
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	12
Start date	1 September 2017
Primary completion	15 May 2019
Estimated completion	5 June 2019
Sites	1 location across Egypt

Drugs / interventions tested

Micro-osteoperforation

Conditions studied

Dental Malocclusions — all drugs for Dental Malocclusions →
Angle Class II, Division 1 — all drugs for Angle Class II, Division 1 →
Bimaxillary Protrusion — all drugs for Bimaxillary Protrusion →

Sponsor

Ahmed Akram Elawady

Who can join

Adults 14 to 18, any sex, with Dental Malocclusions or Angle Class II, Division 1. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the present clinical study was directed to evaluate the effectiveness of micro-osteoperforations on the rate of canine retraction; in addition, the potential risk for root resorption during maxillary canine retraction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Micro-osteoperforation

Trials testing the same drug.

NCT04778241 — Effects of Mini Implant Facilitated Micro-osteoperforations on the Alignment of Mandibular Anterior Crowding · NA · completed
NCT05167708 — Effects of Micro-osteoperforation on the Maxillary First Molar Distalization · NA · completed
NCT04837781 — The Effect of Vitamin D3 on the Rate of Orthodontic Tooth Movement · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04383600 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ahmed Akram Elawady
Last refreshed: 12 May 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04383600.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing